February 27, 2020 / 11:58 AM / a month ago

BRIEF-Neurovasc Secures $34 Mln In Funding To Support Clinical Trials And Product Development

Feb 27 (Reuters) -

* NEUROVASC SECURES $34 MILLION IN FUNDING TO SUPPORT CLINICAL TRIALS AND PRODUCT DEVELOPMENT

* NEUROVASC TECHNOLOGIES - ENTERED INTO A STRATEGIC PARTNERSHIP WITH WEGO GROUP THAT INCLUDES $34 MILLION IN FUNDING Source text for Eikon:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below